McInnes IB, Schett G: The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011, 365: 2205-2219. 10.1056/NEJMra1004965.
Article
CAS
PubMed
Google Scholar
Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, et al: 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010, 69: 1580-1588. 10.1136/ard.2010.138461. Erratum in Ann Rheum Dis 2010, 69:1892.
Article
PubMed
Google Scholar
Trouw LA, Mahler M: Closing the serological gap: promising novel biomarkers for the early diagnosis of rheumatoid arthritis. Autoimmun Rev. 2012, 12: 318-322. 10.1016/j.autrev.2012.05.007.
Article
CAS
PubMed
Google Scholar
Colebatch AN, Edwards CJ, Østergaard M, van der Heijde D, Balint PV, D'Agostino MA, Forslind K, Grassi W, Haavardsholm EA, Haugeberg G, Jurik AG, Landewé RB, Naredo E, O'Connor PJ, Ostendorf B, Potocki K, Schmidt WA, Smolen JS, Sokolovic S, Watt I, Conaghan PG: EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum Dis. 2013, 72: 804-814. 10.1136/annrheumdis-2012-203158.
Article
PubMed
Google Scholar
Filippucci E, Iagnocco A, Salaffi F, Cerioni A, Valesini G, Grassi W: Power Doppler sonography monitoring of synovial perfusion at wrist joints in rheumatoid patients treated with adalimumab. Ann Rheum Dis. 2006, 65: 1433-1437. 10.1136/ard.2005.044628.
Article
CAS
PubMed
PubMed Central
Google Scholar
Freeston JE, Wakefield RJ, Conaghan PG, Hensor EM, Stewart SP, Emery P: A diagnostic algorithm for persistence of very early inflammatory arthritis: the utility of power Doppler ultrasound when added to conventional assessment tools. Ann Rheum Dis. 2010, 69: 417-419. 10.1136/ard.2008.106658.
Article
CAS
PubMed
Google Scholar
Wakefield RJ, D'Agostino MA, Naredo E, Buch MH, Iagnocco A, Terslev L, Ostergaard M, Backhaus M, Grassi W, Dougados M, Burmester GR, Saleem B, de Miguel E, Estrach C, Ikeda K, Gutierrez M, Thompson R, Balint P, Emery P: After treat-to-target: can a targeted ultrasound initiative improve RA outcomes?. Postgrad Med J. 2012, 88: 482-486. 10.1136/postgradmedj-2011-201048rep.
Article
PubMed
Google Scholar
Scirè CA, Montecucco C, Codullo V, Epis O, Todoerti M, Caporali R: Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse. Rheumatology. 2009, 48: 1092-1097. 10.1093/rheumatology/kep171.
Article
PubMed
Google Scholar
Nielsen SF, Bojesen SE, Schnohr P, Nordestgaard BG: Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study. BMJ. 2012, 345: e5244-10.1136/bmj.e5244.
Article
PubMed
PubMed Central
Google Scholar
Hassfeld W, Steiner G, Hartmuth K, Kolarz G, Scherak O, Graninger W, Thumb N, Smolen J: Demonstration of a new antinuclear antibody (anti-RA 33) that is highly specific for rheumatoid arthritis. Arthritis Rheum. 1989, 32: 1515-1520. 10.1002/anr.1780321204.
Article
CAS
PubMed
Google Scholar
Després N, Boire G, Lopez-Longo FJ, Ménard HA: The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis. J Rheumatol. 1994, 21: 1027-1033.
PubMed
Google Scholar
De Rooy DP, Willemze A, Mertens B, Huizinga TW, Van der Helm-van Mil AH: Can anti-cyclic citrullinated peptide antibody-negative RA be subdivided into clinical subphenotypes?. Arthritis Res Ther. 2011, 13: R180-10.1186/ar3505.
Article
CAS
PubMed
PubMed Central
Google Scholar
van Venrooij WJ, van Beers JJ, Pruijn GJ: Anti-CCP antibody, a marker for the early detection of rheumatoid arthritis. Ann N Y Acad Sci. 2008, 1143: 268-285. 10.1196/annals.1443.013.
Article
CAS
PubMed
Google Scholar
Klareskog L, Widhe M, Hermansson M, Ronnelid J: Antibodies to citrullinated proteins in arthritis: pathology and promise. Curr Opin Rheumatol. 2008, 20: 300-305. 10.1097/BOR.0b013e3282fbd22a.
Article
CAS
PubMed
Google Scholar
Szodoray P, Szabó Z, Kapitány A, Gyetvai A, Lakos G, Szántó S, Szücs G, Szekanecz Z: Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis. Autoimmun Rev. 2010, 9: 140-143. 10.1016/j.autrev.2009.04.006.
Article
CAS
PubMed
Google Scholar
Soós L, Szekanecz Z, Szabó Z, Fekete A, Zeher M, Horváth IF, Dankó K, Kapitány A, Végvári A, Sipka S, Szegedi G, Lakos G: Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis. J Rheumatol. 2007, 34: 1658-1663.
PubMed
Google Scholar
van Jaarsveld CH, ter Borg EJ, Jacobs JW, Schellekens GA, Gmelig-Meyling FH, van Booma-Frankfort C, de Jong BA, van Venrooij WJ, Bijlsma JW: The prognostic value of the antiperinuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis. Clin Exp Rheumatol. 1999, 1: 689-697.
Google Scholar
Vincent C, Nogueira L, Clavel C, Sebbag M, Serre G: Autoantibodies to citrullinated proteins: ACPA. Autoimmunity. 2005, 38: 17-24. 10.1080/08916930400022582.
Article
CAS
PubMed
Google Scholar
Szekanecz Z, Soós L, Szabó Z, Fekete A, Kapitány A, Végvári A, Sipka S, Szücs G, Szántó S, Lakos G: Anti-citrullinated protein antibodies in rheumatoid arthritis: as good as it gets?. Clin Rev Allergy Immunol. 2008, 34: 26-31. 10.1007/s12016-007-8022-5.
Article
PubMed
Google Scholar
van der Woude D, Syversen SW, van der Voort EI, Verpoort KN, Goll GL, van der Linden MP, van der Helm-van Mil AH, van der Heijde DM, Huizinga TW, Kvien TK, Toes RE: The ACPA isotype profile reflects long-term radiographic progression in rheumatoid arthritis. Ann Rheum Dis. 2010, 69: 1110-1116. 10.1136/ard.2009.116384.
Article
CAS
PubMed
Google Scholar
Debaugnies F, Servais G, Badot V, Noubouossie D, Willems D, Corazza F: Anti-cyclic citrullinated peptide antibodies: a comparison of different assays for the diagnosis of rheumatoid arthritis. Scand J Rheumatol. 2013, 42: 108-114. 10.3109/03009742.2012.723746.
Article
CAS
PubMed
Google Scholar
Caro-Oleas JL, Fernández-Suárez A, Reneses Cesteros S, Porrino C, Núñez-Roldán A, Wichmann SI: Evaluation of third generation anti-CCP antibodies in the diagnosis of rheumatoid arthritis from undifferentiated polyarthritis after 4 years of follow-up. Clin Exp Rheumatol. 2008, 26: 461-463.
CAS
PubMed
Google Scholar
Szekanecz Z, Szabó Z, Zeher M, Soós L, Dankó K, Horváth I, Lakos G: Superior performance of the CCP3.1 test compared to CCP2 and MCV in the rheumatoid factor-negative RA population. Immunol Res. 2013, 56: 439-443. 10.1007/s12026-013-8425-8.
Article
CAS
PubMed
Google Scholar
van Venrooij WJ, van Beers JJ, Pruijn GJ: Anti-CCP antibodies: the past, the present and the future. Nat Rev Rheumatol. 2011, 7: 391-398. 10.1038/nrrheum.2011.76.
Article
CAS
PubMed
Google Scholar
Rantapää-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, Sundin U, van Venrooij WJ: Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003, 48: 2741-2749. 10.1002/art.11223.
Article
PubMed
Google Scholar
Syversen SW, Goll GL, van der Heijde D, Landewé R, Lie BA, Odegård S, Uhlig T, Gaarder PI, Kvien TK: Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study. Ann Rheum Dis. 2010, 69: 345-351. 10.1136/ard.2009.113092.
Article
CAS
PubMed
Google Scholar
Shi J, Knevel R, Suwannalai P, van der Linden MP, Janssen GM, van Veelen PA, Levarht NE, van der Helm-van Mil AH, Cerami A, Huizinga TW, Toes RE, Trouw LA: Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc Natl Acad Sci U S A. 2011, 108: 17372-17377. 10.1073/pnas.1114465108.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shi J, van de Stadt LA, Levarht EW, Huizinga TW, Hamann D, van Schaardenburg D, Toes RE, Trouw LA: Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis. Ann Rheum Dis. 2014, 73: 780-783. 10.1136/annrheumdis-2013-204154.
Article
CAS
PubMed
Google Scholar
Shi J, van de Stadt LA, Levarht EW, Huizinga TW, Toes RE, Trouw LA, van Schaardenburg D: Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis. Arthritis Rheum. 2013, 65: 911-915. 10.1002/art.37830.
Article
CAS
PubMed
Google Scholar
Somers K, Geusens P, Elewaut D, De Keyser F, Rummens JL, Coenen M, Blom M, Stinissen P, Somers V: Antigens identified by phage display, Novel autoantibody markers for early and seronegative rheumatoid arthritis. J Autoimmun. 2011, 36: 33-46. 10.1016/j.jaut.2010.10.003.
Article
CAS
PubMed
Google Scholar
Bykerk VP: Strategies to prevent rheumatoid arthritis in high-risk patients. Curr Opin Rheumatol. 2011, 23: 179-184.
PubMed
Google Scholar
Grassi W, Filippucci E: Rheumatoid arthritis: diagnosis of RA–we have a dream. Nat Rev Rheumatol. 2013, 9: 202-204. 10.1038/nrrheum.2013.39.
Article
PubMed
Google Scholar